Lijenta 5 Tablet
by Nipro JMI Pharma Ltd
৳22.00
The ACME Laboratories Ltd.
Linagliptin
Linagliptin is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults.
Linagliptin is indicated to improve glycemic control in patients with type 2 diabetes mellitus. Linagliptin is an inhibitor of DPP-4 (dipeptidyl peptidase-4.
Linagliptin 5 mg once daily. If added to metformin, the dose of metformin should be maintained and linagliptin administered concomitantly.
Linagliptin is a weak competitive and a weak to a moderate mechanism-based inhibitor of CYP isozyme CYP3A4 but does not inhibit other CYP isozymes.
Hypersensitivity to the active substance or to any of the excipients.
There may be hypoglycemia, nasopharyngitis, cough, and pancreatitis in combination with metformin and sulfonylurea.
Linagliptin tablets should be used during pregnancy only if clearly needed.
Hypersensitivity to the active substance or to any of the excipients.
Dipeptidyl Peptidase-4 (DPP-4) inhibitor
Keep in a dry place away from light and heat.
ACME Laboratories Ltd.
by Aristopharma Ltd.
৳22.00